Robert Radie
Chairman at ROCKWELL MEDICAL, INC.
Net worth: 54 280 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Strobeck | M | 53 |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA. | 11 years |
| Megan Timmins | F | 52 | 8 years | |
| Andrea Smiley | F | 56 | 7 years | |
| Jonathan Light | M | - | 7 years | |
| Todd Smith | M | 55 | 5 years | |
| David M. Jackson | M | - |
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 8 years |
| Barbara A. Carlin | F | 49 | 11 years | |
| John Cooper | M | 65 | 7 years | |
| Adam Woodrow | M | 57 | 10 years | |
| Christopher Bostrom | M | - | 4 years | |
| Jesse Neri | F | - | 1 years | |
| Evan Tzanis | M | - |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 5 years |
| E. Blair Clark-Schoeb | F | - | 9 years | |
| Mark Ravich | M | 71 | 7 years | |
| Allen Nissenson | M | 77 | 4 years | |
| Randy Hubbell | M | 61 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | - |
| Joan Lau | M | 54 | 1 years | |
| Ivan Philip Gergel | M | 64 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | - |
| Timothy T. Chole | M | - | 5 years | |
| Stacey Seltzer | F | 47 | 1 years | |
| Karen McGrath | F | - | 5 years | |
| Michael DeYoung | M | - | 6 years | |
| Katherine Richman Oates | F | - |
ValSource LLC
 ValSource LLC Pharmaceuticals: MajorHealth Technology ValSource LLC provides consulting and advisory services to the pharmaceutical, advanced therapy medicinal products, biologics, and medical device industries. The private company is based in Downingtown, PA. The company's services aim to ensure the success and speed-to-market of client projects. | 4 years |
| Cary Sucoff | M | 71 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 1 years |
| Marc Hoffman | M | 63 | 5 years | |
| Ulf Meier-Kriesche | M | - | 7 years | |
| Rita L. Mannella | F | - | 7 years | |
| Heather R. Hunter | F | - | 2 years | |
| Greg Parekh | M | - |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | - |
| Raj Padmanabhan | M | - | 9 years | |
| Randy Brenner | M | 51 | 9 years | |
| Robert Ruffolo | M | 74 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 2 years |
| Adam Dilluvio | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Francois Formela | M | 67 |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | 7 years |
| Renée Aguiar-Lucander | F | 62 |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | 3 years |
| Stuart Paul | M | 64 | 2 years | |
| Johnny Stilou | M | 57 | 8 years | |
| Beverly A. Armstrong | F | 55 | - | |
| Michael Heffernan | M | 59 | 5 years | |
| William Haskel | M | 63 | - | |
| Stanley J. Musial | M | 63 |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | 7 years |
| Mette Agger | F | 59 | 8 years | |
| John McLaughlin | M | 72 | 3 years | |
| Alastair Stuart McEwan | M | 69 | 1 years | |
| Russell Ellison | M | 76 | 2 years | |
| Timothy Walbert | M | 57 | 6 years | |
| Raymond Pratt | M | 73 | 10 years | |
| Christine R. Coyne | F | 55 | 4 years | |
| Richard Lim | M | 52 | 4 years | |
| Gary Phillips | M | 58 | 1 years | |
| Benjamin J. Strain | M | - | 3 years | |
| Kristine Peterson | F | 64 | 7 years | |
| Paul McGarry | M | 56 | 4 years | |
| Minnie Baylor-Henry | F | 76 | 2 years | |
| Judith N. Steenbergen | M | - | - | |
| Matthew Pauls | M | 53 | - | |
| Todd Holmes | M | - | 1 years | |
| Douglas Pagán | M | 52 | 5 years | |
| Paul C. Varki | M | - | - | |
| Andrey Kozlov | M | 48 |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | 1 years |
| Joseph McInnis | M | 48 | 1 years | |
| Lisa Colleran | F | 66 | 2 years | |
| Timothy Franson | M | 72 | 8 years | |
| Jeffrey Stein | M | 69 | 9 years | |
| Nicholas C. Nicolaides | M | 58 | 4 years | |
| Paul Wotton | M | 63 | 4 years | |
| Stuart J. M. Collinson | M | 64 |
Affinium Pharmaceuticals Ltd.
 Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | 7 years |
| Elaine Hochberg | F | 67 | 2 years | |
| Robert P. Roche | M | 68 | 3 years | |
| Michael Bigham | M | 66 | 9 years | |
| John E. Osborn | M | 66 | 4 years | |
| Thomas Dietz | M | 60 | 9 years | |
| Gregory Weaver | M | 68 | 6 years | |
| Thomas Dyrberg | M | 69 | 13 years | |
| Ronald Guido | M | 67 | 6 years | |
| Lars Kåre Viksmoen | M | 75 | - | |
| Rolf K. Hoffmann | M | 64 | 5 years | |
| Sarah Higgins | F | 48 | - | |
| Ajay Gupta | M | 66 | 12 years | |
| Patrick Michael Shea | M | 59 | - | |
| Jeanne Jew | F | 61 | 5 years | |
| Jason Burdette | M | - | - | |
| RoN Jackson | M | - | - | |
| Anne Boardman | F | - | 3 years | |
| David Pierce | M | 61 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | - |
| Angus Smith | M | 41 | 2 years | |
| Paul McGovern | M | - | 2 years | |
| Russell Skibsted | M | 65 | - | |
| Yulii Bogatyrenko | M | - | - | |
| Jeffrey Dayno | M | 66 | 3 years | |
| Tim Cochran | M | - | - | |
| Luke Düster | M | 49 | - | |
| Deanne F. Melloy | F | - | - | |
| H. Wilkins | M | 62 | 1 years | |
| John Varian | M | 64 | 1 years | |
| Stephen Villano | M | - | - | |
| Paul Eckburg | M | 53 | - | |
| David Stamler | M | 63 |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | 3 years |
| Hal Craig | M | - | 1 years | |
| Anthony Blandin | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 89 | 89.00% |
| Denmark | 10 | 10.00% |
| United Kingdom | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Radie
- Personal Network
